GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 - the Noble ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback